Inhaled PA9159 for Adults with Moderate Asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new inhaled medicine called PA9159 for adults with moderate asthma. It compares the medicine to a placebo to see if it safely improves breathing and controls asthma symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with asthma by a doctor.
- Your lung function tests show that your asthma is moderate (FEV1 between 60% and 85% of normal).
- You have had a positive test showing that your airways can relax with medication, or have daily peak flow variability over 10%.
- You are able to use a nebulizer correctly.
- You have not had an asthma flare-up needing steroids in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an inhaled asthma medication, PA9159, in adults with stable or mild-to-moderate asthma. It aims to see if the drug improves lung function and is safe. You may qualify if you have asthma with some airflow limitation and have not had recent severe flare-ups.
This trial is testing whether starting treatment with a combination anti-inflammatory and reliever inhaler can help people with new, mild asthma control their symptoms better. It compares different treatment strategies to find the best approach for early asthma care.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This study tests if a new albuterol inhaler works as well as the standard one for people with mild asthma. You'll breathe in a medicine that measures how your lungs respond, helping show the new inhaler is safe and effective.
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.